Skip to content

Clinical trials

Completed Hyperlipidemias trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Status: Completed Country / region: South Korea Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20071
20092
20102
20117
20123
20139
20147
20155
20167
20179
20186
20191
20201
20223
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chong Kun Dang Pharmaceutical7
Yuhan Corporation6
Boryung Pharmaceutical Co., Ltd5
Chonbuk National University Hospital5
Jeil Pharmaceutical Co., Ltd.5
Addpharma Inc.4
Amgen4
Hanmi Pharmaceutical Company Limited4
HK inno.N Corporation3
JW Pharmaceutical3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias68
Hypertension30
Diabetes Mellitus6
Hypercholesterolemia4
Essential Hypertension3
Arteriosclerosis1
Cardiovascular Diseases1
Coronary Artery Disease1
Hypertriglyceridemia1
Overweight1

Trials

Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.